Interact to see
Advertisement
Advertisement
MDDAX vs VIVAX
MDDAX vs VIVAX Comparison
Open Charts MDDAX vs VIVAX
MassMutual Diversified Value A
Price$9.71
Change-$0.00 (-0.00%)
VolumeN/A
Net Assets324.7M
Vanguard Value Index I
Price$66.86
Change-$0.13 (-0.19%)
VolumeN/A
Net Assets188.77B
MDDAX vs VIVAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
VS
MDDAX vs. VIVAX commentary
Jun 06, 2025
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MDDAX is a Buy and VIVAX is a Buy.
FUNDAMENTALS
Fundamentals
VIVAX has more cash in the bank: 189B vs. MDDAX (325M). VIVAX pays higher dividends than MDDAX: VIVAX (2.16) vs MDDAX (1.40). MDDAX was incepted earlier than VIVAX: MDDAX (21 years) vs VIVAX (33 years). MDDAX (1.14) is less costly to investors than VIVAX (0.17). MDDAX is a more actively managed with annual turnover of: 46.00 vs. VIVAX (9.00). MDDAX has a lower initial minimum investment than VIVAX: MDDAX (1000) vs VIVAX (3000). VIVAX annual gain was more profitable for investors over the last year : 6.90 vs. MDDAX (-20.46). VIVAX return over 5 years is better than : 59.01 vs. MDDAX (1.63).
| MDDAX | VIVAX | MDDAX / VIVAX | |
| Total Expense Ratio | 1.14 | 0.17 | 671% |
| Annual Report Gross Expense Ratio | 1.14 | 0.17 | 671% |
| Fund Existence | 21 years | 33 years | - |
| Gain YTD | 1.569 | 1.434 | 109% |
| Front Load | 6% | N/A | - |
| Min. Initial Investment | 1000 | 3000 | 33% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 325M | 189B | 0% |
| Annual Yield % from dividends | 1.40 | 2.16 | 65% |
| Returns for 1 year | -20.46 | 6.90 | -297% |
| Returns for 3 years | -19.14 | 20.08 | -95% |
| Returns for 5 years | 1.63 | 59.01 | 3% |
| Returns for 10 years | -24.31 | 103.66 | -23% |
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| EXHAX | 25.75 | N/A | N/A |
| Manning & Napier Pro-Blend Max Term S | |||
| PCAOX | 79.35 | N/A | N/A |
| Principal Capital Appreciation R3 | |||
| JEMGX | 10.00 | N/A | N/A |
| JHancock Emerging Markets Equity R6 | |||
| FWMNX | 17.07 | N/A | N/A |
| Fidelity Advisor Women's Leadership I | |||
| NSFBX | 8.76 | -0.01 | -0.11% |
| Natixis Target Retirement 2015 N | |||